Data-driven grading of acute graft-versus-host disease
Authors:
- Evren BayraktarEBEvren Bayraktar
- Francis A. AyukFrancis A. Ayuk
- Gernot BeutelGBGernot Beutel
- Olaf PenackOPOlaf Penack
- Thomas LuftTLThomas Luft
- Nicole BruederNBNicole Brueder
- Gastone CastellaniGastone Castellani
- Nicolaus KrögerNKNicolaus Kröger
- Dietrich W. BeelenDBDietrich W. Beelen
- Amin T. TurkiATAmin T. Turki
Open Access
- 28 November 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Abstract
Despite advances in allogeneic hematopoietic cell transplantation, acute graft-versus-host disease (aGVHD) remains its leading complication, yet with heterogeneous outcomes. Here, we analyzed aGVHD phenotypes and clinical classifications in depth in large, multicenter cohorts involving 3019 patients and addressed prevailing gaps by developing data-driven models. We compared, tested and verified these along with all conventional classifications in independent cohorts and found that data-driven grading outperformed conventional grading in Akaike information criterion and concordance index metrics. Data-driven classifications refined aGVHD assessment with up to 12 severity grades, which were associated with distinct nonrelapse mortality (NRM) and confirmed the key role of intestinal aGVHD. We developed an online calculator for physicians to implement principal component-derived grading (PC1). These results provide substantial insight into the evaluation of aGVHD phenotypes and multiorgan involvement, which relegates the exclusive reporting of overall aGVHD severity grades in transplant registries and clinical trials. Data-driven aGVHD grading provides an expandable platform to refine classification and transplant risk assessment.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (FU 356/12-1, PE 1450/7-1)
- Bundesministerium für Forschung, Technologie und Raumfahrt (031L0027)
This publication has 36 references indexed in Scilit:
- Plasma biomarkers of lower gastrointestinal and liver acute GVHDBlood, 2012
- Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseBlood, 2011
- Elafin Is a Biomarker of Graft-Versus-Host Disease of the SkinScience Translational Medicine, 2010
- Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survivalBlood, 2008
- Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective studyBlood, 2005
- IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADEBritish Journal of Haematology, 1997
- New combinatorial clustering methods1989
- The Efficiency of Cox's Likelihood Function for Censored DataJournal of the American Statistical Association, 1977
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958